All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
AWH / Aspira Women's Health Inc.
|
|
|
|
|
|
|
|
SIEN / Sientra, Inc.
|
|
|
|
|
|
|
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
YTEN / Yield10 Bioscience, Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
SILK / Silk Road Medical, Inc
|
|
|
|
|
|
|
|
PXD / Pioneer Natural Resources Company
|
|
|
|
|
|
|
|
ETRN / Equitrans Midstream Corporation
|
|
|
|
|
|
|
|
PGNY / Progyny, Inc.
|
|
|
|
|
|
|
|
GTHX / G1 Therapeutics, Inc.
|
|
|
|
|
|
|
|
KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
DCGO / DocGo Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
ELUT / Elutia Inc.
|
|
|
|
|
|
|
|
TSVT / 2seventy bio, Inc.
|
|
|
|
|
|
|
|
ATEC / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
ANGN / Angion Biomedica Corp
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
CORT / Corcept Therapeutics Incorporated
|
|
|
|
|
|
|
|
OVV / Ovintiv Inc.
|
|
|
|
|
|
|
|
HROW / Harrow, Inc.
|
|
|
|
|
|
|
|
PHR / Phreesia, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
CGEM / Cullinan Therapeutics, Inc.
|
|
|
|
|
|
|
|
GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
IFRX / InflaRx N.V.
|
|
|
|
|
|
|
|
TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
INBX.V / Inhibrx, Inc.
|
|
|
|
|
|
|
|
BDSX / Biodesix, Inc.
|
|
|
|
|
|
|
|
NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|